nodes	percent_of_prediction	percent_of_DWPC	metapath
Zuclopenthixol—Cetirizine—allergic rhinitis	0.415	1	CrCtD
Zuclopenthixol—Amoxapine—Desloratadine—allergic rhinitis	0.0563	0.212	CrCrCtD
Zuclopenthixol—HRH1—Cetirizine—allergic rhinitis	0.0443	0.178	CbGbCtD
Zuclopenthixol—HTR6—Cyproheptadine—allergic rhinitis	0.0376	0.151	CbGbCtD
Zuclopenthixol—Nefazodone—Cetirizine—allergic rhinitis	0.0305	0.115	CrCrCtD
Zuclopenthixol—Thiothixene—Olopatadine—allergic rhinitis	0.0267	0.101	CrCrCtD
Zuclopenthixol—Trazodone—Cetirizine—allergic rhinitis	0.0261	0.0983	CrCrCtD
Zuclopenthixol—HRH1—Dimenhydrinate—allergic rhinitis	0.0255	0.102	CbGbCtD
Zuclopenthixol—Loxapine—Cyproheptadine—allergic rhinitis	0.0218	0.0823	CrCrCtD
Zuclopenthixol—HRH1—Desloratadine—allergic rhinitis	0.0216	0.087	CbGbCtD
Zuclopenthixol—Hydroxyzine—Cetirizine—allergic rhinitis	0.0212	0.08	CrCrCtD
Zuclopenthixol—HRH1—Olopatadine—allergic rhinitis	0.0204	0.0818	CbGbCtD
Zuclopenthixol—Quetiapine—Cetirizine—allergic rhinitis	0.0198	0.0746	CrCrCtD
Zuclopenthixol—HTR2A—Cyproheptadine—allergic rhinitis	0.0197	0.0792	CbGbCtD
Zuclopenthixol—Clozapine—Cyproheptadine—allergic rhinitis	0.0188	0.0707	CrCrCtD
Zuclopenthixol—Chlorprothixene—Olopatadine—allergic rhinitis	0.0187	0.0706	CrCrCtD
Zuclopenthixol—DRD2—Cyproheptadine—allergic rhinitis	0.0181	0.0729	CbGbCtD
Zuclopenthixol—HRH1—Cyproheptadine—allergic rhinitis	0.0164	0.0659	CbGbCtD
Zuclopenthixol—Perphenazine—Cetirizine—allergic rhinitis	0.014	0.0528	CrCrCtD
Zuclopenthixol—HRH1—Loratadine—allergic rhinitis	0.0124	0.05	CbGbCtD
Zuclopenthixol—HRH1—Diphenhydramine—allergic rhinitis	0.0124	0.05	CbGbCtD
Zuclopenthixol—Prochlorperazine—Cetirizine—allergic rhinitis	0.0114	0.0429	CrCrCtD
Zuclopenthixol—CYP2D6—Desloratadine—allergic rhinitis	0.00864	0.0347	CbGbCtD
Zuclopenthixol—CYP2D6—Loratadine—allergic rhinitis	0.00496	0.02	CbGbCtD
Zuclopenthixol—CYP2D6—Diphenhydramine—allergic rhinitis	0.00496	0.02	CbGbCtD
Zuclopenthixol—CYP2D6—Dexamethasone—allergic rhinitis	0.00172	0.0069	CbGbCtD
Zuclopenthixol—HRH1—nose—allergic rhinitis	0.000288	0.312	CbGeAlD
Zuclopenthixol—HTR2A—autonomic nervous system—allergic rhinitis	0.000123	0.133	CbGeAlD
Zuclopenthixol—DRD2—respiratory system—allergic rhinitis	4.78e-05	0.0517	CbGeAlD
Zuclopenthixol—DRD2—eye—allergic rhinitis	4.37e-05	0.0473	CbGeAlD
Zuclopenthixol—Eye disorder—Hydrocortisone—allergic rhinitis	4.29e-05	0.000628	CcSEcCtD
Zuclopenthixol—Nausea—Cetirizine—allergic rhinitis	4.28e-05	0.000626	CcSEcCtD
Zuclopenthixol—Pruritus—Montelukast—allergic rhinitis	4.27e-05	0.000626	CcSEcCtD
Zuclopenthixol—Connective tissue disorder—Methylprednisolone—allergic rhinitis	4.24e-05	0.000621	CcSEcCtD
Zuclopenthixol—Nausea—Flunisolide—allergic rhinitis	4.2e-05	0.000616	CcSEcCtD
Zuclopenthixol—Arrhythmia—Prednisolone—allergic rhinitis	4.2e-05	0.000615	CcSEcCtD
Zuclopenthixol—Visual impairment—Methylprednisolone—allergic rhinitis	4.15e-05	0.000609	CcSEcCtD
Zuclopenthixol—Immune system disorder—Hydrocortisone—allergic rhinitis	4.14e-05	0.000607	CcSEcCtD
Zuclopenthixol—Diarrhoea—Montelukast—allergic rhinitis	4.13e-05	0.000605	CcSEcCtD
Zuclopenthixol—Arrhythmia—Hydrocortisone—allergic rhinitis	4.1e-05	0.0006	CcSEcCtD
Zuclopenthixol—Erythema—Prednisolone—allergic rhinitis	4.09e-05	0.000599	CcSEcCtD
Zuclopenthixol—ADRA1A—epithelium—allergic rhinitis	4.08e-05	0.0441	CbGeAlD
Zuclopenthixol—Eye disorder—Methylprednisolone—allergic rhinitis	4.03e-05	0.00059	CcSEcCtD
Zuclopenthixol—Mental disorder—Hydrocortisone—allergic rhinitis	4.02e-05	0.000589	CcSEcCtD
Zuclopenthixol—Cardiac disorder—Methylprednisolone—allergic rhinitis	4e-05	0.000586	CcSEcCtD
Zuclopenthixol—Erythema—Hydrocortisone—allergic rhinitis	3.99e-05	0.000585	CcSEcCtD
Zuclopenthixol—Malnutrition—Hydrocortisone—allergic rhinitis	3.99e-05	0.000585	CcSEcCtD
Zuclopenthixol—Dizziness—Montelukast—allergic rhinitis	3.99e-05	0.000585	CcSEcCtD
Zuclopenthixol—Angiopathy—Methylprednisolone—allergic rhinitis	3.91e-05	0.000573	CcSEcCtD
Zuclopenthixol—Immune system disorder—Methylprednisolone—allergic rhinitis	3.89e-05	0.00057	CcSEcCtD
Zuclopenthixol—Arrhythmia—Triamcinolone—allergic rhinitis	3.86e-05	0.000565	CcSEcCtD
Zuclopenthixol—Vision blurred—Prednisolone—allergic rhinitis	3.85e-05	0.000565	CcSEcCtD
Zuclopenthixol—Arrhythmia—Methylprednisolone—allergic rhinitis	3.85e-05	0.000564	CcSEcCtD
Zuclopenthixol—Vomiting—Montelukast—allergic rhinitis	3.84e-05	0.000562	CcSEcCtD
Zuclopenthixol—DRD5—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	3.82e-05	0.0176	CbGpPWpGaD
Zuclopenthixol—Rash—Montelukast—allergic rhinitis	3.81e-05	0.000558	CcSEcCtD
Zuclopenthixol—Dermatitis—Montelukast—allergic rhinitis	3.8e-05	0.000557	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Prednisolone—allergic rhinitis	3.79e-05	0.000556	CcSEcCtD
Zuclopenthixol—Headache—Montelukast—allergic rhinitis	3.78e-05	0.000554	CcSEcCtD
Zuclopenthixol—HRH1—respiratory system—allergic rhinitis	3.78e-05	0.0409	CbGeAlD
Zuclopenthixol—Visual impairment—Dexamethasone—allergic rhinitis	3.78e-05	0.000553	CcSEcCtD
Zuclopenthixol—Visual impairment—Betamethasone—allergic rhinitis	3.78e-05	0.000553	CcSEcCtD
Zuclopenthixol—Mental disorder—Methylprednisolone—allergic rhinitis	3.78e-05	0.000553	CcSEcCtD
Zuclopenthixol—Erythema—Triamcinolone—allergic rhinitis	3.76e-05	0.000551	CcSEcCtD
Zuclopenthixol—Malnutrition—Methylprednisolone—allergic rhinitis	3.75e-05	0.00055	CcSEcCtD
Zuclopenthixol—Erythema—Methylprednisolone—allergic rhinitis	3.75e-05	0.00055	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Hydrocortisone—allergic rhinitis	3.71e-05	0.000543	CcSEcCtD
Zuclopenthixol—Malaise—Prednisolone—allergic rhinitis	3.69e-05	0.00054	CcSEcCtD
Zuclopenthixol—Vertigo—Prednisolone—allergic rhinitis	3.67e-05	0.000538	CcSEcCtD
Zuclopenthixol—Syncope—Prednisolone—allergic rhinitis	3.67e-05	0.000537	CcSEcCtD
Zuclopenthixol—Eye disorder—Dexamethasone—allergic rhinitis	3.66e-05	0.000537	CcSEcCtD
Zuclopenthixol—Eye disorder—Betamethasone—allergic rhinitis	3.66e-05	0.000537	CcSEcCtD
Zuclopenthixol—Malaise—Hydrocortisone—allergic rhinitis	3.6e-05	0.000528	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Prednisolone—allergic rhinitis	3.59e-05	0.000527	CcSEcCtD
Zuclopenthixol—Vertigo—Hydrocortisone—allergic rhinitis	3.59e-05	0.000526	CcSEcCtD
Zuclopenthixol—Nausea—Montelukast—allergic rhinitis	3.58e-05	0.000525	CcSEcCtD
Zuclopenthixol—Syncope—Hydrocortisone—allergic rhinitis	3.58e-05	0.000525	CcSEcCtD
Zuclopenthixol—Angiopathy—Dexamethasone—allergic rhinitis	3.56e-05	0.000521	CcSEcCtD
Zuclopenthixol—Angiopathy—Betamethasone—allergic rhinitis	3.56e-05	0.000521	CcSEcCtD
Zuclopenthixol—Convulsion—Prednisolone—allergic rhinitis	3.54e-05	0.000519	CcSEcCtD
Zuclopenthixol—Hypertension—Prednisolone—allergic rhinitis	3.53e-05	0.000517	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Hydrocortisone—allergic rhinitis	3.51e-05	0.000514	CcSEcCtD
Zuclopenthixol—Arrhythmia—Dexamethasone—allergic rhinitis	3.5e-05	0.000513	CcSEcCtD
Zuclopenthixol—Arrhythmia—Betamethasone—allergic rhinitis	3.5e-05	0.000513	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Triamcinolone—allergic rhinitis	3.49e-05	0.000511	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Methylprednisolone—allergic rhinitis	3.48e-05	0.00051	CcSEcCtD
Zuclopenthixol—Convulsion—Hydrocortisone—allergic rhinitis	3.46e-05	0.000507	CcSEcCtD
Zuclopenthixol—HRH1—eye—allergic rhinitis	3.45e-05	0.0373	CbGeAlD
Zuclopenthixol—Hypertension—Hydrocortisone—allergic rhinitis	3.45e-05	0.000505	CcSEcCtD
Zuclopenthixol—Discomfort—Prednisolone—allergic rhinitis	3.44e-05	0.000504	CcSEcCtD
Zuclopenthixol—Erythema—Betamethasone—allergic rhinitis	3.41e-05	0.0005	CcSEcCtD
Zuclopenthixol—Erythema—Dexamethasone—allergic rhinitis	3.41e-05	0.0005	CcSEcCtD
Zuclopenthixol—Myalgia—Hydrocortisone—allergic rhinitis	3.4e-05	0.000498	CcSEcCtD
Zuclopenthixol—Malaise—Triamcinolone—allergic rhinitis	3.39e-05	0.000497	CcSEcCtD
Zuclopenthixol—Anxiety—Hydrocortisone—allergic rhinitis	3.39e-05	0.000496	CcSEcCtD
Zuclopenthixol—Malaise—Methylprednisolone—allergic rhinitis	3.38e-05	0.000496	CcSEcCtD
Zuclopenthixol—Vertigo—Triamcinolone—allergic rhinitis	3.38e-05	0.000495	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	3.38e-05	0.000495	CcSEcCtD
Zuclopenthixol—Syncope—Triamcinolone—allergic rhinitis	3.37e-05	0.000494	CcSEcCtD
Zuclopenthixol—Vertigo—Methylprednisolone—allergic rhinitis	3.37e-05	0.000494	CcSEcCtD
Zuclopenthixol—Syncope—Methylprednisolone—allergic rhinitis	3.36e-05	0.000493	CcSEcCtD
Zuclopenthixol—Discomfort—Hydrocortisone—allergic rhinitis	3.36e-05	0.000492	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Prednisolone—allergic rhinitis	3.34e-05	0.000489	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Triamcinolone—allergic rhinitis	3.3e-05	0.000484	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Methylprednisolone—allergic rhinitis	3.3e-05	0.000483	CcSEcCtD
Zuclopenthixol—Shock—Prednisolone—allergic rhinitis	3.28e-05	0.000481	CcSEcCtD
Zuclopenthixol—DRD5—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	3.27e-05	0.0151	CbGpPWpGaD
Zuclopenthixol—Anaphylactic shock—Hydrocortisone—allergic rhinitis	3.26e-05	0.000478	CcSEcCtD
Zuclopenthixol—Convulsion—Triamcinolone—allergic rhinitis	3.26e-05	0.000477	CcSEcCtD
Zuclopenthixol—Tachycardia—Prednisolone—allergic rhinitis	3.26e-05	0.000477	CcSEcCtD
Zuclopenthixol—Convulsion—Methylprednisolone—allergic rhinitis	3.25e-05	0.000476	CcSEcCtD
Zuclopenthixol—Hypertension—Triamcinolone—allergic rhinitis	3.25e-05	0.000476	CcSEcCtD
Zuclopenthixol—Hypertension—Methylprednisolone—allergic rhinitis	3.24e-05	0.000475	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Prednisolone—allergic rhinitis	3.23e-05	0.000473	CcSEcCtD
Zuclopenthixol—Shock—Hydrocortisone—allergic rhinitis	3.21e-05	0.00047	CcSEcCtD
Zuclopenthixol—Myalgia—Triamcinolone—allergic rhinitis	3.2e-05	0.000469	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Hydrocortisone—allergic rhinitis	3.2e-05	0.000468	CcSEcCtD
Zuclopenthixol—Myalgia—Methylprednisolone—allergic rhinitis	3.19e-05	0.000468	CcSEcCtD
Zuclopenthixol—Anxiety—Methylprednisolone—allergic rhinitis	3.18e-05	0.000466	CcSEcCtD
Zuclopenthixol—Tachycardia—Hydrocortisone—allergic rhinitis	3.18e-05	0.000466	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	3.17e-05	0.000465	CcSEcCtD
Zuclopenthixol—Skin disorder—Hydrocortisone—allergic rhinitis	3.17e-05	0.000464	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Betamethasone—allergic rhinitis	3.17e-05	0.000464	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Dexamethasone—allergic rhinitis	3.17e-05	0.000464	CcSEcCtD
Zuclopenthixol—Discomfort—Triamcinolone—allergic rhinitis	3.16e-05	0.000463	CcSEcCtD
Zuclopenthixol—HRH1—epithelium—allergic rhinitis	3.16e-05	0.0341	CbGeAlD
Zuclopenthixol—Discomfort—Methylprednisolone—allergic rhinitis	3.16e-05	0.000462	CcSEcCtD
Zuclopenthixol—HTR2A—respiratory system—allergic rhinitis	3.15e-05	0.0341	CbGeAlD
Zuclopenthixol—Hyperhidrosis—Hydrocortisone—allergic rhinitis	3.15e-05	0.000462	CcSEcCtD
Zuclopenthixol—Dry mouth—Triamcinolone—allergic rhinitis	3.13e-05	0.000459	CcSEcCtD
Zuclopenthixol—Anorexia—Hydrocortisone—allergic rhinitis	3.11e-05	0.000455	CcSEcCtD
Zuclopenthixol—Malaise—Dexamethasone—allergic rhinitis	3.08e-05	0.000451	CcSEcCtD
Zuclopenthixol—Malaise—Betamethasone—allergic rhinitis	3.08e-05	0.000451	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Triamcinolone—allergic rhinitis	3.07e-05	0.00045	CcSEcCtD
Zuclopenthixol—Vertigo—Dexamethasone—allergic rhinitis	3.07e-05	0.000449	CcSEcCtD
Zuclopenthixol—Vertigo—Betamethasone—allergic rhinitis	3.07e-05	0.000449	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Methylprednisolone—allergic rhinitis	3.06e-05	0.000449	CcSEcCtD
Zuclopenthixol—Syncope—Betamethasone—allergic rhinitis	3.06e-05	0.000448	CcSEcCtD
Zuclopenthixol—Syncope—Dexamethasone—allergic rhinitis	3.06e-05	0.000448	CcSEcCtD
Zuclopenthixol—ADRA2A—bronchus—allergic rhinitis	3.05e-05	0.033	CbGeAlD
Zuclopenthixol—Hypotension—Hydrocortisone—allergic rhinitis	3.05e-05	0.000446	CcSEcCtD
Zuclopenthixol—Shock—Triamcinolone—allergic rhinitis	3.02e-05	0.000442	CcSEcCtD
Zuclopenthixol—Insomnia—Prednisolone—allergic rhinitis	3.02e-05	0.000442	CcSEcCtD
Zuclopenthixol—Shock—Methylprednisolone—allergic rhinitis	3.01e-05	0.000441	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Methylprednisolone—allergic rhinitis	3e-05	0.00044	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Dexamethasone—allergic rhinitis	3e-05	0.000439	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Betamethasone—allergic rhinitis	3e-05	0.000439	CcSEcCtD
Zuclopenthixol—DRD5—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	3e-05	0.0138	CbGpPWpGaD
Zuclopenthixol—Paraesthesia—Prednisolone—allergic rhinitis	3e-05	0.000439	CcSEcCtD
Zuclopenthixol—Tachycardia—Triamcinolone—allergic rhinitis	3e-05	0.000439	CcSEcCtD
Zuclopenthixol—Tachycardia—Methylprednisolone—allergic rhinitis	2.99e-05	0.000438	CcSEcCtD
Zuclopenthixol—Skin disorder—Methylprednisolone—allergic rhinitis	2.97e-05	0.000436	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	2.97e-05	0.000435	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Triamcinolone—allergic rhinitis	2.97e-05	0.000435	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Methylprednisolone—allergic rhinitis	2.96e-05	0.000434	CcSEcCtD
Zuclopenthixol—Convulsion—Betamethasone—allergic rhinitis	2.96e-05	0.000433	CcSEcCtD
Zuclopenthixol—Convulsion—Dexamethasone—allergic rhinitis	2.96e-05	0.000433	CcSEcCtD
Zuclopenthixol—HTR6—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	2.95e-05	0.0136	CbGpPWpGaD
Zuclopenthixol—Insomnia—Hydrocortisone—allergic rhinitis	2.95e-05	0.000432	CcSEcCtD
Zuclopenthixol—Hypertension—Dexamethasone—allergic rhinitis	2.95e-05	0.000432	CcSEcCtD
Zuclopenthixol—Hypertension—Betamethasone—allergic rhinitis	2.95e-05	0.000432	CcSEcCtD
Zuclopenthixol—Paraesthesia—Hydrocortisone—allergic rhinitis	2.93e-05	0.000429	CcSEcCtD
Zuclopenthixol—Myalgia—Dexamethasone—allergic rhinitis	2.9e-05	0.000426	CcSEcCtD
Zuclopenthixol—Myalgia—Betamethasone—allergic rhinitis	2.9e-05	0.000426	CcSEcCtD
Zuclopenthixol—Anxiety—Betamethasone—allergic rhinitis	2.89e-05	0.000424	CcSEcCtD
Zuclopenthixol—Anxiety—Dexamethasone—allergic rhinitis	2.89e-05	0.000424	CcSEcCtD
Zuclopenthixol—HTR2A—eye—allergic rhinitis	2.88e-05	0.0312	CbGeAlD
Zuclopenthixol—Discomfort—Dexamethasone—allergic rhinitis	2.87e-05	0.00042	CcSEcCtD
Zuclopenthixol—Discomfort—Betamethasone—allergic rhinitis	2.87e-05	0.00042	CcSEcCtD
Zuclopenthixol—Dyspepsia—Hydrocortisone—allergic rhinitis	2.87e-05	0.00042	CcSEcCtD
Zuclopenthixol—Hypotension—Methylprednisolone—allergic rhinitis	2.86e-05	0.000419	CcSEcCtD
Zuclopenthixol—Pain—Prednisolone—allergic rhinitis	2.85e-05	0.000418	CcSEcCtD
Zuclopenthixol—Decreased appetite—Hydrocortisone—allergic rhinitis	2.83e-05	0.000415	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	2.81e-05	0.000412	CcSEcCtD
Zuclopenthixol—Fatigue—Hydrocortisone—allergic rhinitis	2.81e-05	0.000412	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	2.8e-05	0.00041	CcSEcCtD
Zuclopenthixol—HRH1—trachea—allergic rhinitis	2.79e-05	0.0302	CbGeAlD
Zuclopenthixol—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	2.79e-05	0.000409	CcSEcCtD
Zuclopenthixol—Pain—Hydrocortisone—allergic rhinitis	2.79e-05	0.000408	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Dexamethasone—allergic rhinitis	2.78e-05	0.000408	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Betamethasone—allergic rhinitis	2.78e-05	0.000408	CcSEcCtD
Zuclopenthixol—Insomnia—Triamcinolone—allergic rhinitis	2.78e-05	0.000407	CcSEcCtD
Zuclopenthixol—Insomnia—Methylprednisolone—allergic rhinitis	2.77e-05	0.000406	CcSEcCtD
Zuclopenthixol—Paraesthesia—Triamcinolone—allergic rhinitis	2.76e-05	0.000404	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Prednisolone—allergic rhinitis	2.75e-05	0.000403	CcSEcCtD
Zuclopenthixol—Paraesthesia—Methylprednisolone—allergic rhinitis	2.75e-05	0.000403	CcSEcCtD
Zuclopenthixol—ADRA2A—trachea—allergic rhinitis	2.74e-05	0.0297	CbGeAlD
Zuclopenthixol—Shock—Dexamethasone—allergic rhinitis	2.74e-05	0.000401	CcSEcCtD
Zuclopenthixol—Shock—Betamethasone—allergic rhinitis	2.74e-05	0.000401	CcSEcCtD
Zuclopenthixol—Dyspnoea—Triamcinolone—allergic rhinitis	2.74e-05	0.000401	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Dexamethasone—allergic rhinitis	2.73e-05	0.0004	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Betamethasone—allergic rhinitis	2.73e-05	0.0004	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Dexamethasone—allergic rhinitis	2.73e-05	0.000399	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Betamethasone—allergic rhinitis	2.73e-05	0.000399	CcSEcCtD
Zuclopenthixol—Tachycardia—Dexamethasone—allergic rhinitis	2.72e-05	0.000398	CcSEcCtD
Zuclopenthixol—Tachycardia—Betamethasone—allergic rhinitis	2.72e-05	0.000398	CcSEcCtD
Zuclopenthixol—Dyspepsia—Triamcinolone—allergic rhinitis	2.7e-05	0.000396	CcSEcCtD
Zuclopenthixol—Dyspepsia—Methylprednisolone—allergic rhinitis	2.7e-05	0.000395	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Dexamethasone—allergic rhinitis	2.69e-05	0.000394	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Betamethasone—allergic rhinitis	2.69e-05	0.000394	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Hydrocortisone—allergic rhinitis	2.69e-05	0.000393	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	2.67e-05	0.00039	CcSEcCtD
Zuclopenthixol—Anorexia—Dexamethasone—allergic rhinitis	2.65e-05	0.000389	CcSEcCtD
Zuclopenthixol—Anorexia—Betamethasone—allergic rhinitis	2.65e-05	0.000389	CcSEcCtD
Zuclopenthixol—Fatigue—Triamcinolone—allergic rhinitis	2.65e-05	0.000388	CcSEcCtD
Zuclopenthixol—Fatigue—Methylprednisolone—allergic rhinitis	2.64e-05	0.000387	CcSEcCtD
Zuclopenthixol—HTR2A—epithelium—allergic rhinitis	2.64e-05	0.0285	CbGeAlD
Zuclopenthixol—ADRA1A—AMPK Signaling—ADIPOQ—allergic rhinitis	2.63e-05	0.0121	CbGpPWpGaD
Zuclopenthixol—Pain—Triamcinolone—allergic rhinitis	2.62e-05	0.000384	CcSEcCtD
Zuclopenthixol—Hypotension—Betamethasone—allergic rhinitis	2.6e-05	0.000381	CcSEcCtD
Zuclopenthixol—Hypotension—Dexamethasone—allergic rhinitis	2.6e-05	0.000381	CcSEcCtD
Zuclopenthixol—Abdominal pain—Hydrocortisone—allergic rhinitis	2.58e-05	0.000377	CcSEcCtD
Zuclopenthixol—Body temperature increased—Hydrocortisone—allergic rhinitis	2.58e-05	0.000377	CcSEcCtD
Zuclopenthixol—DRD5—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	2.57e-05	0.0119	CbGpPWpGaD
Zuclopenthixol—DRD2—lung—allergic rhinitis	2.54e-05	0.0275	CbGeAlD
Zuclopenthixol—DRD1—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	2.54e-05	0.0117	CbGpPWpGaD
Zuclopenthixol—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	2.54e-05	0.000372	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	2.54e-05	0.000372	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Triamcinolone—allergic rhinitis	2.53e-05	0.000371	CcSEcCtD
Zuclopenthixol—HTR6—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	2.53e-05	0.0117	CbGpPWpGaD
Zuclopenthixol—Feeling abnormal—Methylprednisolone—allergic rhinitis	2.52e-05	0.00037	CcSEcCtD
Zuclopenthixol—Insomnia—Dexamethasone—allergic rhinitis	2.52e-05	0.000369	CcSEcCtD
Zuclopenthixol—Insomnia—Betamethasone—allergic rhinitis	2.52e-05	0.000369	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	2.5e-05	0.000367	CcSEcCtD
Zuclopenthixol—Paraesthesia—Dexamethasone—allergic rhinitis	2.5e-05	0.000366	CcSEcCtD
Zuclopenthixol—Paraesthesia—Betamethasone—allergic rhinitis	2.5e-05	0.000366	CcSEcCtD
Zuclopenthixol—DRD5—GPCR ligand binding—PTGDR2—allergic rhinitis	2.49e-05	0.0115	CbGpPWpGaD
Zuclopenthixol—DRD5—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	2.48e-05	0.0115	CbGpPWpGaD
Zuclopenthixol—Hypersensitivity—Prednisolone—allergic rhinitis	2.46e-05	0.00036	CcSEcCtD
Zuclopenthixol—Dyspepsia—Betamethasone—allergic rhinitis	2.45e-05	0.000359	CcSEcCtD
Zuclopenthixol—Dyspepsia—Dexamethasone—allergic rhinitis	2.45e-05	0.000359	CcSEcCtD
Zuclopenthixol—Body temperature increased—Triamcinolone—allergic rhinitis	2.43e-05	0.000355	CcSEcCtD
Zuclopenthixol—Abdominal pain—Methylprednisolone—allergic rhinitis	2.42e-05	0.000355	CcSEcCtD
Zuclopenthixol—Decreased appetite—Betamethasone—allergic rhinitis	2.42e-05	0.000355	CcSEcCtD
Zuclopenthixol—Decreased appetite—Dexamethasone—allergic rhinitis	2.42e-05	0.000355	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	2.4e-05	0.000352	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Betamethasone—allergic rhinitis	2.4e-05	0.000352	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Hydrocortisone—allergic rhinitis	2.4e-05	0.000352	CcSEcCtD
Zuclopenthixol—Fatigue—Dexamethasone—allergic rhinitis	2.4e-05	0.000352	CcSEcCtD
Zuclopenthixol—Fatigue—Betamethasone—allergic rhinitis	2.4e-05	0.000352	CcSEcCtD
Zuclopenthixol—HRH1—IL-4 Signaling Pathway—IL4—allergic rhinitis	2.39e-05	0.0111	CbGpPWpGaD
Zuclopenthixol—Pain—Dexamethasone—allergic rhinitis	2.38e-05	0.000349	CcSEcCtD
Zuclopenthixol—Pain—Betamethasone—allergic rhinitis	2.38e-05	0.000349	CcSEcCtD
Zuclopenthixol—Asthenia—Hydrocortisone—allergic rhinitis	2.34e-05	0.000343	CcSEcCtD
Zuclopenthixol—HTR2A—trachea—allergic rhinitis	2.33e-05	0.0252	CbGeAlD
Zuclopenthixol—HTR6—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	2.31e-05	0.0107	CbGpPWpGaD
Zuclopenthixol—Pruritus—Hydrocortisone—allergic rhinitis	2.31e-05	0.000338	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Betamethasone—allergic rhinitis	2.29e-05	0.000336	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Dexamethasone—allergic rhinitis	2.29e-05	0.000336	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Dexamethasone—allergic rhinitis	2.28e-05	0.000334	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Betamethasone—allergic rhinitis	2.28e-05	0.000334	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Triamcinolone—allergic rhinitis	2.26e-05	0.000331	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Methylprednisolone—allergic rhinitis	2.26e-05	0.000331	CcSEcCtD
Zuclopenthixol—Diarrhoea—Hydrocortisone—allergic rhinitis	2.23e-05	0.000327	CcSEcCtD
Zuclopenthixol—Dizziness—Prednisolone—allergic rhinitis	2.21e-05	0.000323	CcSEcCtD
Zuclopenthixol—Asthenia—Triamcinolone—allergic rhinitis	2.2e-05	0.000323	CcSEcCtD
Zuclopenthixol—Body temperature increased—Dexamethasone—allergic rhinitis	2.2e-05	0.000322	CcSEcCtD
Zuclopenthixol—Abdominal pain—Betamethasone—allergic rhinitis	2.2e-05	0.000322	CcSEcCtD
Zuclopenthixol—Body temperature increased—Betamethasone—allergic rhinitis	2.2e-05	0.000322	CcSEcCtD
Zuclopenthixol—Abdominal pain—Dexamethasone—allergic rhinitis	2.2e-05	0.000322	CcSEcCtD
Zuclopenthixol—Asthenia—Methylprednisolone—allergic rhinitis	2.2e-05	0.000322	CcSEcCtD
Zuclopenthixol—DRD1—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	2.17e-05	0.01	CbGpPWpGaD
Zuclopenthixol—Pruritus—Triamcinolone—allergic rhinitis	2.17e-05	0.000318	CcSEcCtD
Zuclopenthixol—Pruritus—Methylprednisolone—allergic rhinitis	2.17e-05	0.000317	CcSEcCtD
Zuclopenthixol—Dizziness—Hydrocortisone—allergic rhinitis	2.16e-05	0.000316	CcSEcCtD
Zuclopenthixol—Rash—Prednisolone—allergic rhinitis	2.1e-05	0.000308	CcSEcCtD
Zuclopenthixol—Dermatitis—Prednisolone—allergic rhinitis	2.1e-05	0.000308	CcSEcCtD
Zuclopenthixol—Diarrhoea—Methylprednisolone—allergic rhinitis	2.09e-05	0.000307	CcSEcCtD
Zuclopenthixol—Headache—Prednisolone—allergic rhinitis	2.09e-05	0.000306	CcSEcCtD
Zuclopenthixol—Vomiting—Hydrocortisone—allergic rhinitis	2.07e-05	0.000304	CcSEcCtD
Zuclopenthixol—DRD2—G alpha (i) signalling events—PTGDR2—allergic rhinitis	2.06e-05	0.00954	CbGpPWpGaD
Zuclopenthixol—Rash—Hydrocortisone—allergic rhinitis	2.05e-05	0.000301	CcSEcCtD
Zuclopenthixol—Dermatitis—Hydrocortisone—allergic rhinitis	2.05e-05	0.000301	CcSEcCtD
Zuclopenthixol—Headache—Hydrocortisone—allergic rhinitis	2.04e-05	0.000299	CcSEcCtD
Zuclopenthixol—Dizziness—Triamcinolone—allergic rhinitis	2.03e-05	0.000297	CcSEcCtD
Zuclopenthixol—Dizziness—Methylprednisolone—allergic rhinitis	2.02e-05	0.000297	CcSEcCtD
Zuclopenthixol—HRH1—lung—allergic rhinitis	2.01e-05	0.0217	CbGeAlD
Zuclopenthixol—Asthenia—Dexamethasone—allergic rhinitis	2e-05	0.000293	CcSEcCtD
Zuclopenthixol—Asthenia—Betamethasone—allergic rhinitis	2e-05	0.000293	CcSEcCtD
Zuclopenthixol—DRD1—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	1.99e-05	0.0092	CbGpPWpGaD
Zuclopenthixol—Nausea—Prednisolone—allergic rhinitis	1.98e-05	0.00029	CcSEcCtD
Zuclopenthixol—HTR6—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	1.98e-05	0.00915	CbGpPWpGaD
Zuclopenthixol—ADRA2A—lung—allergic rhinitis	1.97e-05	0.0213	CbGeAlD
Zuclopenthixol—Pruritus—Betamethasone—allergic rhinitis	1.97e-05	0.000289	CcSEcCtD
Zuclopenthixol—Pruritus—Dexamethasone—allergic rhinitis	1.97e-05	0.000289	CcSEcCtD
Zuclopenthixol—DRD5—GPCR ligand binding—CYSLTR1—allergic rhinitis	1.96e-05	0.00903	CbGpPWpGaD
Zuclopenthixol—Vomiting—Triamcinolone—allergic rhinitis	1.95e-05	0.000286	CcSEcCtD
Zuclopenthixol—Vomiting—Methylprednisolone—allergic rhinitis	1.95e-05	0.000285	CcSEcCtD
Zuclopenthixol—Nausea—Hydrocortisone—allergic rhinitis	1.94e-05	0.000284	CcSEcCtD
Zuclopenthixol—Rash—Triamcinolone—allergic rhinitis	1.93e-05	0.000283	CcSEcCtD
Zuclopenthixol—Dermatitis—Triamcinolone—allergic rhinitis	1.93e-05	0.000283	CcSEcCtD
Zuclopenthixol—Rash—Methylprednisolone—allergic rhinitis	1.93e-05	0.000283	CcSEcCtD
Zuclopenthixol—Dermatitis—Methylprednisolone—allergic rhinitis	1.93e-05	0.000283	CcSEcCtD
Zuclopenthixol—HTR6—GPCR ligand binding—PTGDR2—allergic rhinitis	1.92e-05	0.00888	CbGpPWpGaD
Zuclopenthixol—Headache—Triamcinolone—allergic rhinitis	1.92e-05	0.000282	CcSEcCtD
Zuclopenthixol—Headache—Methylprednisolone—allergic rhinitis	1.92e-05	0.000281	CcSEcCtD
Zuclopenthixol—DRD2—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	1.92e-05	0.00885	CbGpPWpGaD
Zuclopenthixol—HTR6—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	1.91e-05	0.00884	CbGpPWpGaD
Zuclopenthixol—HTR2A—G alpha (q) signalling events—CYSLTR1—allergic rhinitis	1.91e-05	0.00884	CbGpPWpGaD
Zuclopenthixol—HRH1—G alpha (q) signalling events—CYSLTR1—allergic rhinitis	1.91e-05	0.00882	CbGpPWpGaD
Zuclopenthixol—Diarrhoea—Dexamethasone—allergic rhinitis	1.91e-05	0.000279	CcSEcCtD
Zuclopenthixol—Diarrhoea—Betamethasone—allergic rhinitis	1.91e-05	0.000279	CcSEcCtD
Zuclopenthixol—DRD5—GPCR ligand binding—CCL11—allergic rhinitis	1.89e-05	0.00872	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	1.89e-05	0.00871	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	1.88e-05	0.00869	CbGpPWpGaD
Zuclopenthixol—ADRA1A—G alpha (q) signalling events—CYSLTR1—allergic rhinitis	1.87e-05	0.00865	CbGpPWpGaD
Zuclopenthixol—ADRA2A—G alpha (i) signalling events—PTGDR2—allergic rhinitis	1.85e-05	0.00854	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	1.85e-05	0.00853	CbGpPWpGaD
Zuclopenthixol—Dizziness—Betamethasone—allergic rhinitis	1.84e-05	0.00027	CcSEcCtD
Zuclopenthixol—Dizziness—Dexamethasone—allergic rhinitis	1.84e-05	0.00027	CcSEcCtD
Zuclopenthixol—Nausea—Triamcinolone—allergic rhinitis	1.82e-05	0.000267	CcSEcCtD
Zuclopenthixol—Nausea—Methylprednisolone—allergic rhinitis	1.82e-05	0.000266	CcSEcCtD
Zuclopenthixol—DRD5—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	1.8e-05	0.00832	CbGpPWpGaD
Zuclopenthixol—Vomiting—Betamethasone—allergic rhinitis	1.77e-05	0.000259	CcSEcCtD
Zuclopenthixol—Vomiting—Dexamethasone—allergic rhinitis	1.77e-05	0.000259	CcSEcCtD
Zuclopenthixol—Rash—Dexamethasone—allergic rhinitis	1.76e-05	0.000257	CcSEcCtD
Zuclopenthixol—Rash—Betamethasone—allergic rhinitis	1.76e-05	0.000257	CcSEcCtD
Zuclopenthixol—Dermatitis—Dexamethasone—allergic rhinitis	1.75e-05	0.000257	CcSEcCtD
Zuclopenthixol—Dermatitis—Betamethasone—allergic rhinitis	1.75e-05	0.000257	CcSEcCtD
Zuclopenthixol—Headache—Dexamethasone—allergic rhinitis	1.74e-05	0.000256	CcSEcCtD
Zuclopenthixol—Headache—Betamethasone—allergic rhinitis	1.74e-05	0.000256	CcSEcCtD
Zuclopenthixol—ADRA2A—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	1.72e-05	0.00792	CbGpPWpGaD
Zuclopenthixol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—CYSLTR1—allergic rhinitis	1.71e-05	0.00791	CbGpPWpGaD
Zuclopenthixol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CYSLTR1—allergic rhinitis	1.71e-05	0.00789	CbGpPWpGaD
Zuclopenthixol—DRD1—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	1.71e-05	0.00788	CbGpPWpGaD
Zuclopenthixol—HTR2A—SIDS Susceptibility Pathways—IL13—allergic rhinitis	1.69e-05	0.00779	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—CYSLTR1—allergic rhinitis	1.68e-05	0.00774	CbGpPWpGaD
Zuclopenthixol—HTR2A—lung—allergic rhinitis	1.68e-05	0.0181	CbGeAlD
Zuclopenthixol—DRD1—GPCR ligand binding—PTGDR2—allergic rhinitis	1.66e-05	0.00765	CbGpPWpGaD
Zuclopenthixol—Nausea—Dexamethasone—allergic rhinitis	1.65e-05	0.000242	CcSEcCtD
Zuclopenthixol—Nausea—Betamethasone—allergic rhinitis	1.65e-05	0.000242	CcSEcCtD
Zuclopenthixol—DRD1—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	1.65e-05	0.00761	CbGpPWpGaD
Zuclopenthixol—DRD2—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	1.64e-05	0.00758	CbGpPWpGaD
Zuclopenthixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	1.62e-05	0.00746	CbGpPWpGaD
Zuclopenthixol—HRH1—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	1.61e-05	0.00744	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	1.58e-05	0.0073	CbGpPWpGaD
Zuclopenthixol—HTR2A—SIDS Susceptibility Pathways—TAC1—allergic rhinitis	1.55e-05	0.00717	CbGpPWpGaD
Zuclopenthixol—DRD1—Circadian rythm related genes—ADIPOQ—allergic rhinitis	1.54e-05	0.0071	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR ligand binding—CYSLTR1—allergic rhinitis	1.51e-05	0.00697	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	1.5e-05	0.00694	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	1.48e-05	0.00683	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	1.48e-05	0.00682	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	1.47e-05	0.00679	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR ligand binding—CCL11—allergic rhinitis	1.46e-05	0.00673	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	1.45e-05	0.00669	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR downstream signaling—PTGDR2—allergic rhinitis	1.41e-05	0.0065	CbGpPWpGaD
Zuclopenthixol—HTR6—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	1.39e-05	0.00642	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR ligand binding—TAC1—allergic rhinitis	1.37e-05	0.00634	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	1.35e-05	0.00622	CbGpPWpGaD
Zuclopenthixol—HTR2A—G alpha (q) signalling events—TAC1—allergic rhinitis	1.34e-05	0.0062	CbGpPWpGaD
Zuclopenthixol—HRH1—G alpha (q) signalling events—TAC1—allergic rhinitis	1.34e-05	0.00619	CbGpPWpGaD
Zuclopenthixol—ADRA1A—G alpha (q) signalling events—TAC1—allergic rhinitis	1.31e-05	0.00607	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR ligand binding—CYSLTR1—allergic rhinitis	1.3e-05	0.006	CbGpPWpGaD
Zuclopenthixol—DRD2—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	1.29e-05	0.00595	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—PTGDR2—allergic rhinitis	1.28e-05	0.00591	CbGpPWpGaD
Zuclopenthixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	1.27e-05	0.00585	CbGpPWpGaD
Zuclopenthixol—HRH1—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	1.26e-05	0.00584	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR ligand binding—CCL11—allergic rhinitis	1.25e-05	0.0058	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR ligand binding—PTGDR2—allergic rhinitis	1.25e-05	0.00577	CbGpPWpGaD
Zuclopenthixol—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	1.24e-05	0.00575	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	1.24e-05	0.00573	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR ligand binding—PTGDR2—allergic rhinitis	1.23e-05	0.00568	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR ligand binding—PTGDR2—allergic rhinitis	1.23e-05	0.00567	CbGpPWpGaD
Zuclopenthixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	1.22e-05	0.00565	CbGpPWpGaD
Zuclopenthixol—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	1.22e-05	0.00564	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR ligand binding—PTGDR2—allergic rhinitis	1.2e-05	0.00556	CbGpPWpGaD
Zuclopenthixol—HRH1—IL-4 Signaling Pathway—NFKB1—allergic rhinitis	1.2e-05	0.00556	CbGpPWpGaD
Zuclopenthixol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	1.2e-05	0.00555	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	1.2e-05	0.00554	CbGpPWpGaD
Zuclopenthixol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	1.2e-05	0.00554	CbGpPWpGaD
Zuclopenthixol—DRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	1.2e-05	0.00553	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Melatonin metabolism and effects—NFKB1—allergic rhinitis	1.18e-05	0.00543	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	1.18e-05	0.00543	CbGpPWpGaD
Zuclopenthixol—DRD2—Circadian rythm related genes—ADIPOQ—allergic rhinitis	1.16e-05	0.00536	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	1.15e-05	0.00533	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR ligand binding—PTGDR2—allergic rhinitis	1.12e-05	0.00517	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	1.11e-05	0.00514	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR downstream signaling—CYSLTR1—allergic rhinitis	1.1e-05	0.0051	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—PTGDR2—allergic rhinitis	1.09e-05	0.00502	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR ligand binding—TAC1—allergic rhinitis	1.06e-05	0.00489	CbGpPWpGaD
Zuclopenthixol—HTR2A—SIDS Susceptibility Pathways—IL10—allergic rhinitis	1.06e-05	0.00487	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—CYSLTR1—allergic rhinitis	1e-05	0.00463	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	9.94e-06	0.00459	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—PTGDR2—allergic rhinitis	9.87e-06	0.00456	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR ligand binding—CYSLTR1—allergic rhinitis	9.81e-06	0.00453	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—CCL11—allergic rhinitis	9.69e-06	0.00448	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR ligand binding—CYSLTR1—allergic rhinitis	9.65e-06	0.00446	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR ligand binding—CYSLTR1—allergic rhinitis	9.63e-06	0.00445	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR ligand binding—CCL11—allergic rhinitis	9.47e-06	0.00438	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR ligand binding—CYSLTR1—allergic rhinitis	9.45e-06	0.00436	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—PTGDR2—allergic rhinitis	9.36e-06	0.00432	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR ligand binding—CCL11—allergic rhinitis	9.32e-06	0.00431	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR ligand binding—CCL11—allergic rhinitis	9.3e-06	0.0043	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR ligand binding—CCL11—allergic rhinitis	9.13e-06	0.00422	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR ligand binding—TAC1—allergic rhinitis	9.12e-06	0.00421	CbGpPWpGaD
Zuclopenthixol—DRD2—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	9.04e-06	0.00417	CbGpPWpGaD
Zuclopenthixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	8.89e-06	0.00411	CbGpPWpGaD
Zuclopenthixol—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	8.87e-06	0.0041	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR ligand binding—CYSLTR1—allergic rhinitis	8.78e-06	0.00406	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	8.71e-06	0.00402	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—CYSLTR1—allergic rhinitis	8.53e-06	0.00394	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—PTGDR2—allergic rhinitis	8.5e-06	0.00392	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR ligand binding—CCL11—allergic rhinitis	8.48e-06	0.00392	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	8.09e-06	0.00374	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR downstream signaling—TAC1—allergic rhinitis	7.75e-06	0.00358	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—CYSLTR1—allergic rhinitis	7.74e-06	0.00358	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—PTGDR2—allergic rhinitis	7.55e-06	0.00349	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—CCL11—allergic rhinitis	7.48e-06	0.00345	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—CYSLTR1—allergic rhinitis	7.34e-06	0.00339	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR downstream signaling—IL5—allergic rhinitis	7.21e-06	0.00333	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—PTGDR2—allergic rhinitis	7.06e-06	0.00326	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—TAC1—allergic rhinitis	7.04e-06	0.00325	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—PTGDR2—allergic rhinitis	6.95e-06	0.00321	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—PTGDR2—allergic rhinitis	6.94e-06	0.0032	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR ligand binding—TAC1—allergic rhinitis	6.88e-06	0.00318	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—PTGDR2—allergic rhinitis	6.81e-06	0.00314	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR ligand binding—TAC1—allergic rhinitis	6.77e-06	0.00313	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR ligand binding—TAC1—allergic rhinitis	6.76e-06	0.00312	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—CYSLTR1—allergic rhinitis	6.67e-06	0.00308	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR ligand binding—TAC1—allergic rhinitis	6.63e-06	0.00306	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—IL5—allergic rhinitis	6.55e-06	0.00302	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—CCL11—allergic rhinitis	6.44e-06	0.00297	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—PTGDR2—allergic rhinitis	6.41e-06	0.00296	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—PTGDR2—allergic rhinitis	6.32e-06	0.00292	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—PTGDR2—allergic rhinitis	6.31e-06	0.00292	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—PTGDR2—allergic rhinitis	6.3e-06	0.00291	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—PTGDR2—allergic rhinitis	6.18e-06	0.00285	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR ligand binding—TAC1—allergic rhinitis	6.16e-06	0.00285	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—TAC1—allergic rhinitis	5.98e-06	0.00276	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—CYSLTR1—allergic rhinitis	5.93e-06	0.00274	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—PTGDR2—allergic rhinitis	5.83e-06	0.00269	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—PTGDR2—allergic rhinitis	5.74e-06	0.00265	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—CCL11—allergic rhinitis	5.72e-06	0.00264	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—IL5—allergic rhinitis	5.56e-06	0.00257	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—CYSLTR1—allergic rhinitis	5.54e-06	0.00256	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—CYSLTR1—allergic rhinitis	5.45e-06	0.00252	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—CYSLTR1—allergic rhinitis	5.44e-06	0.00251	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—TAC1—allergic rhinitis	5.43e-06	0.00251	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—CYSLTR1—allergic rhinitis	5.34e-06	0.00247	CbGpPWpGaD
Zuclopenthixol—HTR2A—SIDS Susceptibility Pathways—NFKB1—allergic rhinitis	5.16e-06	0.00238	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—TAC1—allergic rhinitis	5.15e-06	0.00238	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—IL5—allergic rhinitis	5.12e-06	0.00237	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—IL5—allergic rhinitis	5.05e-06	0.00233	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—CYSLTR1—allergic rhinitis	5.03e-06	0.00232	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—PTGDR2—allergic rhinitis	5.02e-06	0.00232	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—CYSLTR1—allergic rhinitis	4.96e-06	0.00229	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—CYSLTR1—allergic rhinitis	4.95e-06	0.00229	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—CYSLTR1—allergic rhinitis	4.94e-06	0.00228	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—CCL11—allergic rhinitis	4.86e-06	0.00225	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—CYSLTR1—allergic rhinitis	4.85e-06	0.00224	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—IL5—allergic rhinitis	4.79e-06	0.00221	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—CCL11—allergic rhinitis	4.78e-06	0.00221	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—CCL11—allergic rhinitis	4.77e-06	0.0022	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—CCL11—allergic rhinitis	4.68e-06	0.00216	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—TAC1—allergic rhinitis	4.68e-06	0.00216	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CYSLTR1—allergic rhinitis	4.58e-06	0.00211	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—CYSLTR1—allergic rhinitis	4.51e-06	0.00208	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CCL11—allergic rhinitis	4.42e-06	0.00204	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—CCL11—allergic rhinitis	4.35e-06	0.00201	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—IL5—allergic rhinitis	4.35e-06	0.00201	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—TAC1—allergic rhinitis	4.16e-06	0.00192	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CYSLTR1—allergic rhinitis	3.94e-06	0.00182	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—TAC1—allergic rhinitis	3.89e-06	0.0018	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IL5—allergic rhinitis	3.87e-06	0.00179	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—TAC1—allergic rhinitis	3.83e-06	0.00177	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—TAC1—allergic rhinitis	3.82e-06	0.00176	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CCL11—allergic rhinitis	3.8e-06	0.00176	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PTGDR2—allergic rhinitis	3.79e-06	0.00175	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—TAC1—allergic rhinitis	3.75e-06	0.00173	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PTGDR2—allergic rhinitis	3.73e-06	0.00172	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PTGDR2—allergic rhinitis	3.72e-06	0.00172	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PTGDR2—allergic rhinitis	3.65e-06	0.00169	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—IL5—allergic rhinitis	3.62e-06	0.00167	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—IL5—allergic rhinitis	3.56e-06	0.00164	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—IL5—allergic rhinitis	3.55e-06	0.00164	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—TAC1—allergic rhinitis	3.53e-06	0.00163	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—IL5—allergic rhinitis	3.48e-06	0.00161	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—TAC1—allergic rhinitis	3.48e-06	0.00161	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—TAC1—allergic rhinitis	3.48e-06	0.00161	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—TAC1—allergic rhinitis	3.47e-06	0.0016	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—TAC1—allergic rhinitis	3.4e-06	0.00157	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PTGDR2—allergic rhinitis	3.39e-06	0.00157	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—IL5—allergic rhinitis	3.28e-06	0.00152	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—IL5—allergic rhinitis	3.24e-06	0.0015	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—IL5—allergic rhinitis	3.23e-06	0.00149	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—IL5—allergic rhinitis	3.22e-06	0.00149	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—TAC1—allergic rhinitis	3.21e-06	0.00148	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—IL5—allergic rhinitis	3.16e-06	0.00146	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—TAC1—allergic rhinitis	3.16e-06	0.00146	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IL5—allergic rhinitis	2.98e-06	0.00138	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CYSLTR1—allergic rhinitis	2.97e-06	0.00137	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	2.96e-06	0.00137	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—IL5—allergic rhinitis	2.94e-06	0.00136	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CYSLTR1—allergic rhinitis	2.93e-06	0.00135	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CYSLTR1—allergic rhinitis	2.92e-06	0.00135	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CCL11—allergic rhinitis	2.87e-06	0.00133	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CYSLTR1—allergic rhinitis	2.86e-06	0.00132	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CCL11—allergic rhinitis	2.83e-06	0.00131	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CCL11—allergic rhinitis	2.82e-06	0.0013	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CCL11—allergic rhinitis	2.77e-06	0.00128	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TAC1—allergic rhinitis	2.76e-06	0.00128	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—SMAD3—allergic rhinitis	2.72e-06	0.00126	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CYSLTR1—allergic rhinitis	2.66e-06	0.00123	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CCL11—allergic rhinitis	2.57e-06	0.00119	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IL5—allergic rhinitis	2.57e-06	0.00119	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—SMAD3—allergic rhinitis	2.1e-06	0.00097	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TAC1—allergic rhinitis	2.09e-06	0.000964	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TAC1—allergic rhinitis	2.05e-06	0.000948	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TAC1—allergic rhinitis	2.05e-06	0.000946	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TAC1—allergic rhinitis	2.01e-06	0.000929	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IL5—allergic rhinitis	1.94e-06	0.000896	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IL5—allergic rhinitis	1.91e-06	0.000882	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IL5—allergic rhinitis	1.9e-06	0.00088	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IL5—allergic rhinitis	1.87e-06	0.000863	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TAC1—allergic rhinitis	1.87e-06	0.000863	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—SMAD3—allergic rhinitis	1.81e-06	0.000835	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IL5—allergic rhinitis	1.74e-06	0.000802	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—TGFB1—allergic rhinitis	1.53e-06	0.000705	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—NFKB1—allergic rhinitis	1.38e-06	0.000639	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—SMAD3—allergic rhinitis	1.37e-06	0.000631	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—SMAD3—allergic rhinitis	1.34e-06	0.00062	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—SMAD3—allergic rhinitis	1.34e-06	0.000619	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—SMAD3—allergic rhinitis	1.32e-06	0.000608	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—SMAD3—allergic rhinitis	1.22e-06	0.000565	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—TGFB1—allergic rhinitis	1.15e-06	0.000532	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—NFKB1—allergic rhinitis	1.07e-06	0.000493	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—NFKB1—allergic rhinitis	9.19e-07	0.000425	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—TGFB1—allergic rhinitis	8.89e-07	0.000411	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TGFB1—allergic rhinitis	7.66e-07	0.000354	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—NFKB1—allergic rhinitis	6.94e-07	0.000321	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—NFKB1—allergic rhinitis	6.83e-07	0.000315	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—NFKB1—allergic rhinitis	6.81e-07	0.000315	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—NFKB1—allergic rhinitis	6.69e-07	0.000309	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—NFKB1—allergic rhinitis	6.21e-07	0.000287	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TGFB1—allergic rhinitis	5.78e-07	0.000267	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TGFB1—allergic rhinitis	5.69e-07	0.000263	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TGFB1—allergic rhinitis	5.68e-07	0.000262	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TGFB1—allergic rhinitis	5.57e-07	0.000257	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TGFB1—allergic rhinitis	5.18e-07	0.000239	CbGpPWpGaD
